.Amgen has shared (PDF) the initial period 3 data on its $400 million eczema drug, connecting the an...
.Biogen and UCB's rely on improving in to phase 3 astride an unsuccessful research looks to have rep...
.Italian biotech Aptadir Therapeutics has actually released along with the promise that its pipe of ...
.Wave Lifestyle Sciences has met its own target in a Duchenne muscle dystrophy (DMD) study, position...
.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma fold, using up the ...
.Achilles Therapeutics has shreded its method. The British biotech is actually quiting working on it...
.Aligos Therapeutics is heralding a midstage gain in metabolic-dysfunction associated steatohepatiti...
.Basilea Pharmaceutica's job building brand new antifungals has gotten a significant boost from the ...
.Possessing actually gathered up the U.S. civil liberties to Capricor Therapeutics' late-stage Duche...
.After pushing back the decision date for Applied Therapies' metabolic condition medication govorest...